tirzepatide serotonin syndrome & NMS — Taming the SRU Tirzepatide and Antidepressants: Safety Guide

Slower titration or temporary dose reduction may be necessary for some patients experiencing significant gastrointestinal symptoms

A varied and balanced diet and a healthy lifestyle are essential conditions for good health

Healthcare providers consider multiple factors when recommending either medication, including the patient's health needs, weight loss goals, and cardiovascular health considerations

While most people tolerate semaglutide for weight loss well, some may experience mild side effects like nausea or digestive issues

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans

Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2